Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound.
第一作者:
Binfeng,Xia
第一单位:
Department Drug Metabolism and Pharmacokinetics, Novartis Institute for Biomedical Research, One Health Plaza 436 3253, East Hanover, New Jersey 07936, USA.
作者:
主题词
投药, 口服(Administration, Oral);动物(Animals);交叉研究(Cross-Over Studies);狗(Dogs);食品药物相互作用(Food-Drug Interactions);人类(Humans);模型, 生物学(Models, Biological);药代动力学(Pharmacokinetics);溶解度(Solubility)
DOI
10.1208/s12249-013-0018-2
PMID
23955148
发布时间
2021-10-21
- 浏览4

AAPS PharmSciTech
1255-66页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文